ASLAN Pharmaceuticals Lim... (ASLN)
NASDAQ: ASLN
· Real-Time Price · USD
0.60
-0.10 (-14.27%)
At close: Jul 18, 2024, 10:00 PM
ASLAN Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.09 | -0.05 | -0.27 | -2.55 | -0.18 | -0.14 | -0.31 | -0.21 | -0.39 | -0.68 | -1.16 | -3.39 | -2.05 |
PEG Ratio | 0.00 | -0.00 | -0.00 | 0.03 | -0.01 | -0.00 | 0.02 | n/a | -0.01 | -0.08 | -0.02 | 0.08 | 0.21 |
PS Ratio | n/a | n/a | n/a | 1.60 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -0.2 | -0.22 | -11.74 | 3.01 | 1.38 | 0.96 | 0.61 | 0.34 | 0.45 | 0.43 | 0.58 | 0.98 | 0.68 |
P/FCF Ratio | n/a | n/a | n/a | n/a | n/a | -1.29 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
P/OCF Ratio | n/a | n/a | n/a | n/a | n/a | -1.29 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | -1.48 | -2.02 | -43.47 | 5.95 | 3.84 | 4.50 | 1.66 | 1.12 | 0.81 | 0.54 | 0.46 | 0.21 | 0.19 |
Quick Ratio | 1.05 | 1.84 | 2.11 | 2.26 | 2.59 | 2.63 | 5.08 | 6.97 | 9.63 | 14.75 | 16.60 | 18.50 | 18.31 |
Current Ratio | 1.05 | 1.84 | 2.11 | 2.26 | 2.59 | 2.63 | 5.08 | 6.97 | 9.63 | 14.75 | 16.60 | 18.50 | 18.31 |
Asset Turnover | n/a | n/a | n/a | 0.22 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -13.95 | -12.94 | -9.21 | -2.1 | -16.84 | -17.21 | -10.99 | -14.02 | -10.98 | -14.89 | -16.12 | -38.51 | -16.66 |
Return on Equity | 0.55 | 1.02 | 11.01 | -0.3 | -1.93 | -1.73 | -0.5 | -0.39 | -0.29 | -0.16 | -0.13 | -0.07 | -0.08 |
Return on Assets | -0.47 | -0.55 | -0.22 | -0.03 | -0.32 | -0.24 | -0.15 | -0.16 | -0.14 | -0.1 | -0.08 | -0.06 | -0.07 |
Return on Invested Capital | -1.07 | -0.95 | -0.28 | -0.06 | -0.38 | -0.29 | -0.18 | -0.18 | -0.15 | -0.13 | -0.08 | -0.09 | -0.07 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | 1.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | -0.16 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | -0.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | -0.2 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | -0.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |